TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.850
-0.070 (-1.79%)
Mar 27, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $236.03 million as of March 30, 2026. Its market cap has increased by 46.05% in one year.
Market Cap
236.03M
Enterprise Value
250.03M
1-Year Change
46.05%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $236.03M, a decrease of -28.20%. That is a compound annual growth rate of -6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 236.03M | -32.32% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senseonics Holdings | 274.01M |
| ClearPoint Neuro | 269.05M |
| RxSight | 258.33M |
| BrainsWay | 243.18M |
| CVRx, Inc. | 234.44M |
| Profound Medical | 224.21M |
| 908 Devices | 216.06M |
| Sight Sciences | 209.54M |